Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Spikevax Market Report 2025

Spikevax Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (COVID-19), By Formulation (Spikevax Original, Spikevax Bivalent (Original Or Omicron), Spikevax XBB.1.5), By Age Group (Adults, Adolescents, Children), By Distribution Channel (Government Channels, Hospitals, Clinics)

Spikevax Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Spikevax Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Spikevax Market Definition

Spikevax is a vaccine designed to prevent coronavirus disease 2019 (COVID-19) in individuals aged 6 months and older. It was originally developed with an active ingredient called elasomeran, a messenger RNA (mRNA) molecule that carries genetic instructions for cells to produce a spike protein from the original SARS-CoV-2 strain, helping the immune system recognize and combat the virus.

The main clinical indication for spikevax is COVID-19. COVID-19 is a viral respiratory disease caused by SARS-CoV-2, resulting in symptoms such as fever, cough, and breathing issues. Spikevax is an mRNA-based vaccine, which works by instructing cells in the body to produce a protein similar to the spike protein found on the surface of the virus. This helps the immune system recognize and combat the covid virus if it enters the body. Various formulations are available for the spikevax such as spikevax original, spikevax bivalent (original or omicron), and spikevax XBB.1.5. It is distributed through various channels such as government channels, hospitals, and clinics and used by various age groups such as adults, adolescents, and children.

Spikevax Market Segmentation

The spikevax market covered in this report is segmented –

1) By Clinical Indication: COVID-19

2) By Formulation: Spikevax Original; Spikevax Bivalent (Original Or Omicron); Spikevax XBB.1.5

3) By Age Group: Adults; Adolescents; Children

4) By Distribution Channel: Government Channels; Hospitals; Clinics

Spikevax Market Size and growth rate 2025 to 2029: Graph

Spikevax Market Size 2025 And Growth Rate

The spikevax market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rise in need for COVID-19 vaccines during the pandemic, rise in government funding, rapid regulatory approvals, rise in global vaccination campaigns, high efficacy against SARS-CoV-2 and its variants, and rise in partnerships for large-scale production and distribution.

Spikevax Market Growth Forecast

The spikevax market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising booster shot campaigns, emergence of new SARS-CoV-2 variants, rising government contracts for pandemic preparedness, increasing vaccination rates in developing countries, expansion into pediatric and adolescent populations, and rising regulatory approvals for variant-specific formulations. Major trends in the forecast period include development of bivalent vaccines targeting multiple COVID-19 variants, advancements in storage system, enhanced mRNA technology for faster production, and integration of digital tools for vaccine tracking and monitoring.

Book your 30 minutes free consultation with our research experts

Contact Us

Spikevax Market Driver: Rising COVID-19 Cases Drive Growth In The Market

The rise in the prevalence of COVID cases is expected to propel the growth of the spikevax market going forward. COVID-19 is a disease caused by the SARS-CoV-2 virus, spreading through respiratory droplets and causing symptoms from mild fever to severe respiratory issues. Vaccines and hygiene practices help prevent its spread. COVID-19 cases are increasing due to factors such as new variants, reduced immunity, eased restrictions, seasonal indoor gatherings, and uneven vaccine coverage. Spikevax treat COVID-19 by teaching the immune system to recognize and combat the virus through an mRNA-induced spike protein, offering strong protection against severe disease and variants. For instance, in March 2023, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, as of March 2023, an estimated 1.9 million people in the UK (2.9% of the population) reported long COVID. Most (92%) had COVID-19 over 12 weeks earlier, with 69% experiencing symptoms for over a year and 41% for over two years. Therefore, the rise in the prevalence of COVID cases will drive the growth of the spikevax market forward.

Spikevax Market Driver: Rising Healthcare Investments Driving Growth In The Market

The rise in healthcare investments is expected to drive the growth of the spikevax market going forward. Healthcare investments refer to the total amount spent on healthcare services, including medical treatments, medications, and hospital care, within a specific period. Healthcare investments are rising due to factors such as an aging population, increasing healthcare needs, advancements in medical technology, and rising prices for services and medications. Healthcare investments drive Spikevax adoption by funding vaccine procurement, enhancing infrastructure, and improving delivery systems, thereby ensuring wider accessibility and supporting public health efforts. For instance, In May 2024, according to a report published by the Office for National Statistics, a UK-based government department for official statistics, total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, the rise in healthcare investments is going to drive the growth of the spikevax market forward.

Global Spikevax Market Major Players

Major companies operating in the spikevax market are Moderna Inc.

Spikevax Market Merger And Acquisition: Moderna And Thermo Fisher Partner To Boost U.S. Production Of mRNA Medicines

In February 2022, Moderna Inc., a US-based biotechnology company, partnered with Thermo Fisher Scientific Inc. to boost U.S.-based production of Spikevax and other mRNA therapies. Thermo Fisher's extensive manufacturing services align with Moderna's objectives to scale production and advance its mRNA platform. Thermo Fisher Scientific Inc. is a US-based biotechnology company that specializes in the development and manufacture of life-changing therapies such as mRNA medicines.

Regional Analysis For The Global Spikevax Market

North America was the largest region in the spikevax market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spikevax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spikevax market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Spikevax Market?

The spikevax market consists of sales of COVID-19 vaccines, bivalent booster vaccines, syringes, and needles. Values in this market are ‘factory gate’ values, representing the value of vaccines sold directly by manufacturers, either to governments, healthcare organizations, or distribution networks. This includes revenues from related services but excludes resales further along the supply chain or integration into other healthcare products.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Spikevax Industry?

The spikevax market research report is one of a series of new reports from The Business Research Company that provides spikevax market statistics, including the spikevax industry's global market size, regional shares, competitors with a spikevax market share, detailed spikevax market segments, market trends and opportunities, and any further data you may need to thrive in the spikevax industry. This spikevax market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Spikevax Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The spikevax market covered in this report is segmented –
1) By Clinical Indication: COVID-19
2) By Formulation: Spikevax Original; Spikevax Bivalent (Original Or Omicron); Spikevax XBB.1.5
3) By Age Group: Adults; Adolescents; Children
4) By Distribution Channel: Government Channels; Hospitals; Clinics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Moderna Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Spikevax Market Characteristics

    3. Spikevax Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Spikevax Market Trends And Strategies

    5. Spikevax Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Spikevax Growth Analysis And Strategic Analysis Framework

    6.1. Global Spikevax PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Spikevax Market Growth Rate Analysis

    6.4. Global Spikevax Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Spikevax Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Spikevax Total Addressable Market (TAM)

    7. Global Spikevax Pricing Analysis & Forecasts

    8. Spikevax Market Segmentation

    8.1. Global Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    COVID-19

    8.2. Global Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Spikevax Original

    Spikevax Bivalent (Original Or Omicron)

    Spikevax XBB.1.5

    8.3. Global Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adults

    Adolescents

    Children

    8.4. Global Spikevax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Government Channels

    Hospitals

    Clinics

    9. Global Spikevax Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Spikevax Market Regional And Country Analysis

    10.1. Global Spikevax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Spikevax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Spikevax Market

    11.1. Asia-Pacific Spikevax Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Spikevax Market

    12.1. China Spikevax Market Overview

    12.2. China Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Spikevax Market

    13.1. India Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Spikevax Market

    14.1. Japan Spikevax Market Overview

    14.2. Japan Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Spikevax Market

    15.1. Australia Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Spikevax Market

    16.1. South Korea Spikevax Market Overview

    16.2. South Korea Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Spikevax Market

    17.1. Western Europe Spikevax Market Overview

    17.2. Western Europe Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Spikevax Market

    18.1. UK Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Spikevax Market

    19.1. Germany Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Spikevax Market

    20.1. France Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Spikevax Market

    21.1. Eastern Europe Spikevax Market Overview

    21.2. Eastern Europe Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Spikevax Market

    22.1. North America Spikevax Market Overview

    22.2. North America Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Spikevax Market

    23.1. USA Spikevax Market Overview

    23.2. USA Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Spikevax Market

    24.1. Canada Spikevax Market Overview

    24.2. Canada Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Spikevax Market

    25.1. South America Spikevax Market Overview

    25.2. South America Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Spikevax Market

    26.1. Middle East Spikevax Market Overview

    26.2. Middle East Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Spikevax Market

    27.1. Africa Spikevax Market Overview

    27.2. Africa Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Spikevax Market Competitive Landscape And Company Profiles

    28.1. Spikevax Market Competitive Landscape

    28.2. Spikevax Market Company Profiles

    28.2.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

    28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.5. 0 Overview, Products and Services, Strategy and Financial Analysis

    29. Global Spikevax Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Spikevax Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Spikevax Market

    32. Recent Developments In The Spikevax Market

    33. Spikevax Market High Potential Countries, Segments and Strategies

    33.1 Spikevax Market In 2029 - Countries Offering Most New Opportunities

    33.2 Spikevax Market In 2029 - Segments Offering Most New Opportunities

    33.3 Spikevax Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Spikevax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Spikevax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Spikevax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Moderna Inc. Financial Performance
  • Table 61: 0 Financial Performance
  • Table 62: 0 Financial Performance
  • Table 63: 0 Financial Performance
  • Table 64: 0 Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Spikevax Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Spikevax Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Spikevax Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Spikevax Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Spikevax Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Spikevax Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Moderna Inc. Financial Performance
  • Figure 61: 0 Financial Performance
  • Figure 62: 0 Financial Performance
  • Figure 63: 0 Financial Performance
  • Figure 64: 0 Financial Performance

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the microbiome market research report 2022 with industry size, share, segments and market growth

Read More

Convenience, Mom And Pop Stores Market 2021 - By Type (Convenience Stores, Mom And Pop Stores), By Ownership (Retail Chain, Independent Retailer), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Immunity Boosting Food Products Market 2024 – By Product Source (Herbs And Species, Nuts And Seeds, Fruits And Vegetables, Dairy-Based Products, Prebiotics, Other Product Sources), By Form (Tablets, Capsules, Powder, Liquid, Other Forms), By Distribution Channel (Store-Based, Non-Store-Based), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

COVID-19 Current Therapy Global Market Report 2025 – By Drug Type (Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs, Others), By Route Of Administration (Oral, Intravenous), By End-User (Hospitals, Clinics, Home Care, Others) – Market Size, Trends, And Global Forecast 2025-2035

View Report

COVID-19 Drug Associated APIs Global Market Report 2025 – By Drug Class (Antimalarials, Bronchodilators, Antibiotics, Antivirals, Other Drug Class), By Synthesis Type (Synthetic, Biotech), By Business Mode (Captive API, Merchant API) – Market Size, Trends, And Global Forecast 2025-2034

View Report

COVID-19 Detection Test Kits and Consumables Global Market Report 2025 – By Kits (Viral Load Testing Kits (qPCR and RT-PCR), Virus Neutralizing Assay Kits, Antibody Detection Kits (Elisa), Viral Antigen Detection Test Kits, Other Kits), By Consumables (Swabs, Tubes, Viral Transfer Media, Reagents, Other Consumables), By Specimen Type (Nose & Throat Swab, Blood, Sputum, Nasal Aspirate), By End Use (Hospitals, Clinics, Public Health Labs, Private And Commercial Labs, Physicians Labs, Research Institutes, Other End Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cybersecurity Services Market - By Security Type (Network Security, Endpoint Security, Application Security, Cloud security) By User Type (Large enterprises, Small And medium enterprises) And By Region, Opportunities And Strategies - Global Cybersecurity Services Market Forecast To 2030

View Report

Next Generation Sequencing Market - By Product Type (Kits And Consumables, Software, Instruments), By Technology (Ion Semiconductor Sequencing, Sequencing by Synthesis, Single-molecule Real-time Sequencing, Other Sequencing Technologies, Nanopore Sequencing), By Application (Drug Discovery, Diagnostics, Telepsychiatry), And By Region, Opportunities And Strategies – Global Next Generation Sequencing Market Forecast To 2030

View Report

Medication Adherence Market 2021 - By Type (Hardware Centric, Software Centric), By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Spikevax market?

Spikevax is a vaccine designed to prevent coronavirus disease 2019 (COVID-19) in individuals aged 6 months and older. It was originally developed with an active ingredient called elasomeran, a messenger RNA (mRNA) molecule that carries genetic instructions for cells to produce a spike protein from the original SARS-CoV-2 strain, helping the immune system recognize and combat the virus. For further insights on the Spikevax market, request a sample here

How will the Spikevax market drivers and restraints affect the market dynamics? What forces will shape the Spikevax industry going forward?

The Spikevax market major growth driver - Rising COVID-19 Cases Drive Growth In The Market. For further insights on the Spikevax market, request a sample here

What is the forecast market size or the forecast market value of the Spikevax market?

The Spikevax market size has grown strongly in recent years. The spikevax market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rise in need for COVID-19 vaccines during the pandemic, rise in government funding, rapid regulatory approvals, rise in global vaccination campaigns, high efficacy against SARS-CoV-2 and its variants, and rise in partnerships for large-scale production and distribution. The spikevax market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising booster shot campaigns, emergence of new SARS-CoV-2 variants, rising government contracts for pandemic preparedness, increasing vaccination rates in developing countries, expansion into pediatric and adolescent populations, and rising regulatory approvals for variant-specific formulations. Major trends in the forecast period include development of bivalent vaccines targeting multiple COVID-19 variants, advancements in storage system, enhanced mRNA technology for faster production, and integration of digital tools for vaccine tracking and monitoring. For further insights on the Spikevax market, request a sample here

How is the Spikevax market segmented?

The spikevax market covered in this report is segmented –
1) By Clinical Indication: COVID-19
2) By Formulation: Spikevax Original; Spikevax Bivalent (Original Or Omicron); Spikevax XBB.1.5
3) By Age Group: Adults; Adolescents; Children
4) By Distribution Channel: Government Channels; Hospitals; Clinics For further insights on the Spikevax market, request a sample here

Which region has the largest share of the Spikevax market? What are the other regions covered in the report?

North America was the largest region in the spikevax market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spikevax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Spikevax market, request a sample here.

Who are the major players in the Spikevax market?

Major companies operating in the spikevax market are Moderna Inc. . For further insights on the Spikevax market, request a sample here.

What are the key trends in the Spikevax market?

Major trends in the Spikevax market include . For further insights on the Spikevax market, request a sample here.

What are the major opportunities in the Spikevax market? What are the strategies for the Spikevax market?

For detailed insights on the major opportunities and strategies in the Spikevax market, request a sample here.

How does the Spikevax market relate to the overall economy and other similar markets?

For detailed insights on Spikevax's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Spikevax industry?

For detailed insights on the mergers and acquisitions in the Spikevax industry, request a sample here.

What are the key dynamics influencing the Spikevax market growth? SWOT analysis of the Spikevax market.

For detailed insights on the key dynamics influencing the Spikevax market growth and SWOT analysis of the Spikevax industry, request a sample here.